• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Canada - Harper Government strengthening pandemic vaccine production capacity to help protect Canadians

Pathfinder

Editor, Senior Moderator
News Release

May 14, 2013
For immediate release

Harper Government strengthening pandemic vaccine production capacity to help protect Canadians

(Ottawa) ? The Harper Government, in partnership with the Government of Quebec and GlaxoSmithKline Inc., is strengthening Canada?s pandemic flu vaccine production capacity with significant investments into the manufacturer?s facility in Sainte-Foy, Quebec.
2013_0514b.jpg

Jacques Gourde, MP for Lotbini?re?Chutes-
de-la-Chaudi?re toured the GSK facility in
Sainte-Foy, Quebec along with GSK President Paul
Lirette and Quebec Minister of Finance and the
Economy Nicolas Marceau. The vaccine
manufacturer will increase its pandemic vaccine
filling capacity, thanks in part to a Government of
Canada investment.

?The Harper Government is committed to protecting the health and safety of Canadians and their families,? said Jacques Gourde, Member of Parliament for Lotbini?re?Chutes‑de-la-Chaudi?re on behalf of the Honourable Leona Aglukkaq, Minister of Health. ?Our Government continues to work with industry partners such as GlaxoSmithKline Inc., to ensure that Canadians have rapid, priority access to pandemic vaccine in the event of an influenza pandemic.?

The Harper Government has contracted GlaxoSmithKline to provide vaccines in the event of an influenza pandemic. Since it can take several months to develop a safe and effective vaccine that protects against a pandemic influenza virus, having strong production capacity is vitally important.

GlaxoSmithKline?s modernized fill-line will more than double its pandemic vaccine production capacity from 14 million doses per month to 33 million doses per month by November 2014. This means that during an influenza pandemic, once a vaccine is developed, it can be produced and made available to every Canadian faster.

Vaccines are the cornerstones of Canada?s plan for responding to a pandemic and for the prevention of seasonal flu. The Harper Government?s significant investment reinforces its commitment to supporting immunization in Canada as a fundamental tool for preventing influenza outbreaks and pandemic.

...
http://www.phac-aspc.gc.ca/media/nr-rp/2013/2013_0514b-eng.php
 
Back
Top